For instance, polymorphisms in the promoter regions of the UCP2 gene have been associated with an enhanced risk for T2D in obese subjects [197] and variations in insulin secretion in glucose-tolerant subjects [198]. The gene discussed is INS; the disease is type 2 diabetes mellitus.